XML 59 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
OPERATING ACTIVITIES    
Net income including non-controlling interests $ 23,161 $ 15,242
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation and amortization 4,682 4,181
Provision for doubtful accounts 3,094 3,377
Equity-based awards compensation expense 2,456 2,092
Loss on sale of business and sale or abandonment of assets, net 20 7,233
Excess tax benefit from exercise of stock options (526) (277)
Deferred income tax 3,888 (543)
Changes in operating assets and liabilities:    
Increase in patient accounts receivable (4,952) (3,318)
(Increase) decrease in accounts receivable - other (62) (41)
Decrease in other assets (1,803) 1,148
(Decrease) increase in accounts payable and accrued expenses (1,739) (899)
Increase in other Long term liabilities 607 664
Net cash provided by operating activities 28,826 28,859
INVESTING ACTIVITIES    
Purchase of fixed assets (3,912) (3,458)
Purchase of businesses, net of cash acquired (12,240) (10,128)
Acquisitions of non-controlling interests (4,998) (1,668)
Proceeds on sale of business and fixed assets, net 43 448
Net cash used in investing activities (21,107) (14,806)
FINANCING ACTIVITIES    
Distributions to non-controlling interests (7,067) (6,588)
Cash dividends to shareholders (4,399) (3,628)
Proceeds from revolving line of credit 112,300 88,450
Payments on revolving line of credit (105,800) (91,700)
Payment of notes payable (575) (459)
Excess tax benefit from stock options exercised 526 277
Proceeds from exercise of stock options 45 0
Other 177 47
Net cash used in financing activities (4,793) (13,601)
Net increase in cash 2,926 452
Cash - beginning of period 12,898 11,671
Cash - end of period 15,824 12,123
Cash paid during the period for:    
Income taxes 7,920 4,402
Interest 857 352
Non-cash investing and financing transactions during the period:    
Purchase of business - seller financing portion 400 800
Revaluation of redeemable non-controlling interests $ 1,841 $ 0